Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Sponsor: Ionis Pharmaceuticals, Inc.
Summary
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Official title: A Phase 2, Open-label Trial Evaluating the Safety, Tolerability and Efficacy of ION775 in Adults With Hypertriglyceridemia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2026-05-12
Completion Date
2028-03
Last Updated
2026-06-15
Healthy Volunteers
No
Interventions
ION775
ION775 will be administered by SC injection.
Locations (8)
Ionis Investigative Site
Lincoln, California, United States
Ionis Investigative Site
Miami, Florida, United States
Ionis Investigative Site
Miramar, Florida, United States
Ionis Investigative Site
Flint, Michigan, United States
Ionis Investigative Site
Munroe Falls, Ohio, United States
Ionis Investigative Site
Little River, South Carolina, United States
Ionis Investigative Site
Lampasas, Texas, United States
Ionis Investigative Site
San Antonio, Texas, United States